ArticleFrontiers in neurology
Development and validation of a machine learning model for predicting stroke-associated pneumonia in older patients with acute ischemic stroke.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Stroke-associated pneumonia (SAP) is a common and serious complication in older patients with acute ischemic stroke (AIS). However, early identification of high-risk patients remains challenging. This study aimed to develop and validate an interpretable machine learning model for predicting SAP risk in older AIS patients. Methods: This retrospective study included 1,011 eligible patients (aged ≥65 years) with AIS who were consecutively admitted to Zhejiang Hospital in China from September 1, 2018, to December 31, 2023. A total of 1,011 patients were randomly divided into training and testing sets (7:3 ratio). Demographics, comorbidities, laboratory test results, and admission assessments were collected to evaluate the risk of SAP. The synthetic minority oversampling technique (SMOTE) was used to address the imbalanced training data. The Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to filter the predictive features. Eight machine learning models, including Logistic Regression (LR), Support Vector Machine (SVM), Light Gradient Boosting Machine (LightGBM), eXtreme Gradient Boosting (XGBoost), Categorical Boosting (CatBoost), Gradient Boosting Decision Tree (GBDT), Multi-layer Perceptron (MLP), and Random Forest (RF), were applied to identify the best prediction model. The optimal model was interpreted using the SHapley Additive exPlanations (SHAP). Results: SAP incidence was 18.79%. LASSO identified 12 predictive features. The SVM demonstrated acceptable and stable predictive performance, achieving an accuracy of 0.773, sensitivity of 0.667, specificity of 0.798, F1 score of 0.524, Brier score of 0.156, and AUC of 0.794 (95% CI: 0.748-0.839) in the test set. SHAP analysis identified key factors influencing model predictions. An online platform was developed for clinical use. Conclusion: This study demonstrates that an interpretable SVM-based machine learning model can effectively predict the risk of SAP in older patients with AIS using routinely available clinical and laboratory data. SHAP analysis further improved the model's clinical interpretability by elucidating feature contributions. Our online prediction platform could serve as a promising tool for identifying high-risk older patients and facilitating the early prophylactic management of SAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.